The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Enhanced Ferroptosis by Oxygen-Boosted Phototherapy Based on a 2-in-1 Nanoplatform of Ferrous Hemoglobin for Tumor Synergistic Therapy
Abstract
Photodynamic therapy (PDT) combined with oxygenating strategies is widely employed in cancer treatment; however, oxygen-boosted PDT has failed to achieve an ideal effect due to the complexity, heterogeneity, and irreversible hypoxic environment generated by tumor tissues. With the emergence of Fe-dependent ferroptosis boasting reactive oxygen species (ROS) cytotoxicity as well, such a chemodynamic approach to cancer therapy has drawn extensive attention. In this study, hemoglobin (Hb) is connected with the photosensitizer chlorin e6 (Ce6) to construct a 2-in-1 nanoplatform (SRF@Hb-Ce6) with Sorafenib (SRF, ferroptosis promotor) loaded, combining oxygen-boosted PDT and potent ferroptosis. Benefiting from the intrinsic presence of Fe capable of binding oxygen, hemoglobin concurrently furnishes oxygen for oxygen-dependent PDT and Fe for Fe-dependent ferroptosis. Furthermore, amphiphilic MMP2-responsive peptide is incorporated into the skeleton of the nanoplatform to ensure drug-release specificity for safety improvement. Correlative measurements demonstrate the potentiation of PDT and ferroptosis with SRF@Hb-Ce6. More importantly, PDT strengthens ferroptosis by recruiting immune cells to secrete IFN-γ, which can sensitize the tumor to ferroptosis in our findings. The therapeutic effect of synergistic treatment with SRF@Hb-Ce6 in vitro and in vivo was proven significant, revealing the promising prospects of combined PDT and ferroptosis therapy with the 2-in-1 nanoplatform.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cai, X., Xie, Z., Ding, B., Shao, S., Liang, S., Pang, M., & Lin, J. (2019) · Advanced Science · doi:10.1002/advs.201900848 · Cited by 213
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
FSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880
Photodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
Fluorescence probes used for detection of reactive oxygen species
Gomes, A., Fernandes, E., & Lima, J. L. F. C. (2005) · Journal of Biochemical and Biophysical Methods · doi:10.1016/j.jbbm.2005.10.003 · Cited by 1,844
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., Rosenberg, P. A., Lo, D. C., Weinberg, J. M., Linkermann, A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411006a · Cited by 1,146
Zilka, O., Shah, R., Li, B., Friedmann Angeli, J. P., Griesser, M., Conrad, M., & Pratt, D. A. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00028 · Cited by 1,038
PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals
Wenzel, S. E., Tyurina, Y. Y., Zhao, J., St. Croix, C. M., Dar, H. H., Mao, G., Tyurin, V. A., Anthonymuthu, T. S., Kapralov, A. A., Amoscato, A. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.044 · Cited by 950
Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy
Latunde-Dada, G. O. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.05.019 · Cited by 892
Zou, Y., Palte, M. J., Deik, A. A., Li, H., Eaton, J. K., Wang, W., Tseng, Y.-Y., Deasy, R., Kost-Alimova, M., Dančík, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09277-9 · Cited by 887
He, C., Duan, X., Guo, N., Chan, C., Poon, C., Weichselbaum, R. R., & Lin, W. (2016) · Nature Communications · doi:10.1038/ncomms12499 · Cited by 754
Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis
Sun, X., Niu, X., Chen, R., He, W., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28574 · Cited by 703
Xu, J., Xu, L., Wang, C., Yang, R., Zhuang, Q., Han, X., Dong, Z., Zhu, W., Peng, R., & Liu, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b00715 · Cited by 695
Modulating ROS to overcome multidrug resistance in cancer
Cui, Q., Wang, J.-Q., Assaraf, Y. G., Ren, L., Gupta, P., Wei, L., Ashby, C. R., Yang, D.-H., & Chen, Z.-S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.11.001 · Cited by 661
Characterization of ferroptosis in murine models of hemochromatosis
Wang, H., An, P., Xie, E., Wu, Q., Fang, X., Gao, H., Zhang, Z., Li, Y., Wang, X., Zhang, J., et al. (2017) · Hepatology · doi:10.1002/hep.29117 · Cited by 660
Molecular mechanisms of ferroptosis and its role in cancer therapy
Xu, T., Ding, W., Ji, X., Ao, X., Liu, Y., Yu, W., & Wang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14511 · Cited by 639
Self-citationCancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
Courtnay, R., Ngo, D. C., Malik, N., Ververis, K., Tortorella, S. M., & Karagiannis, T. C. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3858-x · Cited by 567
Liu, T., Liu, W., Zhang, M., Yu, W., Gao, F., Li, C., Wang, S.-B., Feng, J., & Zhang, X.-Z. (2018) · ACS Nano · doi:10.1021/acsnano.8b05860 · Cited by 524
Dong, Z., Feng, L., Hao, Y., Chen, M., Gao, M., Chao, Y., Zhao, H., Zhu, W., Liu, J., Liang, C., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11036 · Cited by 490
Li, S., Zou, Q., Li, Y., Yuan, C., Xing, R., & Yan, X. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b04912 · Cited by 483
Self-citationZhang, Z., Yao, Z., Wang, L., Ding, H., Shao, J., Chen, A., Zhang, F., & Zheng, S. (2018) · Autophagy · doi:10.1080/15548627.2018.1503146 · Cited by 474
Dong, Z., Feng, L., Chao, Y., Hao, Y., Chen, M., Gong, F., Han, X., Zhang, R., Cheng, L., & Liu, Z. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b03905 · Cited by 437
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Luo, M., Wu, L., Zhang, K., Wang, H., Zhang, T., Gutierrez, L., O’Connell, D., Zhang, P., Li, Y., Gao, T., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0053-8 · Cited by 408
Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor
Phua, S. Z. F., Yang, G., Lim, W. Q., Verma, A., Chen, H., Thanabalu, T., & Zhao, Y. (2019) · ACS Nano · doi:10.1021/acsnano.9b01087 · Cited by 375
Nanocatalytic Tumor Therapy by Single-Atom Catalysts
Huo, M., Wang, L., Wang, Y., Chen, Y., & Shi, J. (2019) · ACS Nano · doi:10.1021/acsnano.9b00457 · Cited by 368
Chen, Z., Liu, L., Liang, R., Luo, Z., He, H., Wu, Z., Tian, H., Zheng, M., Ma, Y., & Cai, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b04371 · Cited by 363
Self-citationModeling the effects of lipid peroxidation during ferroptosis on membrane properties
Agmon, E., Solon, J., Bassereau, P., & Stockwell, B. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-23408-0 · Cited by 344
Aggressive Man‐Made Red Blood Cells for Hypoxia‐Resistant Photodynamic Therapy
Liu, W., Liu, T., Zou, M., Yu, W., Li, C., He, Z., Zhang, M., Liu, M., Li, Z., Feng, J., et al. (2018) · Advanced Materials · doi:10.1002/adma.201802006 · Cited by 310
Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism
Chen, P.-H., Wu, J., Ding, C.-K. C., Lin, C.-C., Pan, S., Bossa, N., Xu, Y., Yang, W.-H., Mathey-Prevot, B., & Chi, J.-T. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0393-7 · Cited by 287
Mitochondria in cancer: Not just innocent bystanders
Frezza, C., & Gottlieb, E. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.008 · Cited by 268
Meng, L., Cheng, Y., Tong, X., Gan, S., Ding, Y., Zhang, Y., Wang, C., Xu, L., Zhu, Y., Wu, J., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b03590 · Cited by 268
Zhu, T., Shi, L., Yu, C., Dong, Y., Qiu, F., Shen, L., Qian, Q., Zhou, G., & Zhu, X. (2019) · Theranostics · doi:10.7150/thno.32867 · Cited by 264
Ji, T., Lang, J., Wang, J., Cai, R., Zhang, Y., Qi, F., Zhang, L., Zhao, X., Wu, W., Hao, J., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b01026 · Cited by 222
Deng, F., Sharma, I., Dai, Y., Yang, M., & Kanwar, Y. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129903 · Cited by 221
A Physiological Function for Ferroptosis in Tumor Suppression by the Immune System
Stockwell, B. R., & Jiang, X. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.012 · Cited by 203
BECN1 is a new driver of ferroptosis
Kang, R., Zhu, S., Zeh, H. J., Klionsky, D. J., & Tang, D. (2018) · Autophagy · doi:10.1080/15548627.2018.1513758 · Cited by 189
Li, S., Zhang, Y., Wang, J., Zhao, Y., Ji, T., Zhao, X., Ding, Y., Zhao, X., Zhao, R., Li, F., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0115-8 · Cited by 171
Self-citationCombined Fenton and starvation therapies using hemoglobin and glucose oxidase
Ranji‐Burachaloo, H., Reyhani, A., Gurr, P. A., Dunstan, D. E., & Qiao, G. G. (2019) · Nanoscale · doi:10.1039/c8nr09107b · Cited by 138
Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy
Zhang, C., Gao, F., Wu, W., Qiu, W., Zhang, L., Li, R., Zhuang, Z., Yu, W., Cheng, H. L., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.9b04315 · Cited by 136
Yu, H., Li, J., Deng, K., Zhou, W., Wang, C., Wang, Q., Li, K., Zhao, H., & Huang, S. (2019) · Theranostics · doi:10.7150/thno.35748 · Cited by 69
Li, Y., Lin, J., Zhi, X., Li, P., Jiang, X., & Yuan, J. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.05.073 · Cited by 56
Interferon-γ induces cancer cell ferroptosis
Zitvogel, L., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0186-z · Cited by 48
Cited by
Ferroptosis: Mechanisms and links with diseases
Yan, H.-F., Zou, T., Tuo, Q.-Z., Xu, S., Li, H., Belaidi, A. A., & Lei, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00428-9 · Cited by 1,471
Conquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
Xiong, Y., Xiao, C., Li, Z., & Yang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00718h · Cited by 692
Ferroptosis in cancer and cancer immunotherapy
Zhao, L., Zhou, X., Xie, F., Zhang, L., Yan, H., Huang, J., Zhang, C., Zhou, F., Chen, J., & Zhang, L. (2022) · Cancer Communications · doi:10.1002/cac2.12250 · Cited by 684
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Sun, S., Shen, J., Jiang, J., Wang, F., & Min, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01606-1 · Cited by 608
Metadata
- Authors
- Xu, T., Ma, Y., Yuan, Q., Hu, H., Hu, X., Qian, Z., Rolle, J. K., Gu, Y., & Li, S.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-03-10
- Volume
- 14
- Issue
- 3
- Pages
- 3414-3425
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W3011061347
- Cited by
- 316
- References
- 50
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.